YARS Antikörper (N-Term)
-
- Target Alle YARS (Yars) Antikörper anzeigen
- YARS (Yars) (Tyrosyl-tRNA Synthetase (Yars))
-
Bindungsspezifität
- AA 160-190, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser YARS Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Homologie
- Rat
- Aufreinigung
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Immunogen
- This Tyrosyl tRNA synthetase (YARS) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 160-190 amino acids from the N-terminal region of human Tyrosyl tRNA synthetase (YARS).
- Klon
- RB14873
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product Yars Primärantikörper
-
-
- Applikationshinweise
- WB: 1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- Haltbarkeit
- 6 months
-
-
Alternative splicing creates two new architectures for human tyrosyl-tRNA synthetase." in: Nucleic acids research, Vol. 44, Issue 3, pp. 1247-55, (2016) (PubMed).
: "
-
Alternative splicing creates two new architectures for human tyrosyl-tRNA synthetase." in: Nucleic acids research, Vol. 44, Issue 3, pp. 1247-55, (2016) (PubMed).
-
- Target
- YARS (Yars) (Tyrosyl-tRNA Synthetase (Yars))
- Andere Bezeichnung
- Tyrosyl tRNA synthetase (YARS) (Yars Produkte)
- Synonyme
- CMTDIC antikoerper, TYRRS antikoerper, YRS antikoerper, YTS antikoerper, AL024047 antikoerper, AU018965 antikoerper, cb204 antikoerper, wu:fk52b08 antikoerper, YARS antikoerper, cmtdic antikoerper, tyrrs antikoerper, yrs antikoerper, yts antikoerper, CG4561 antikoerper, Dmel\\CG4561 antikoerper, TyrRS antikoerper, anon-EST:Posey261 antikoerper, dYARS antikoerper, GB10789 antikoerper, tyrosyl-tRNA synthetase antikoerper, tyrosyl-tRNA synthetase L homeolog antikoerper, tyrosyl-tRNA synthetase, putative antikoerper, tyrosine--tRNA ligase antikoerper, Tyrosyl-tRNA synthetase antikoerper, tyrosine--tRNA ligase, cytoplasmic antikoerper, YARS antikoerper, Yars antikoerper, yars antikoerper, yars.L antikoerper, MAL8P1.125 antikoerper, MEFER_RS04475 antikoerper, TyrRS antikoerper, LOC413909 antikoerper, LOC100163888 antikoerper, LOC100282315 antikoerper
- Hintergrund
- Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Tyrosyl-tRNA synthetase belongs to the class I tRNA synthetase family. Cytokine activities have also been observed for the human tyrosyl-tRNA synthetase, after it is split into two parts, an N-terminal fragment that harbors the catalytic site and a C-terminal fragment found only in the mammalian enzyme. The N-terminal fragment is an interleukin-8-like cytokine, whereas the released C-terminal fragment is an EMAP II-like cytokine.
- Molekulargewicht
- 59143
- Gen-ID
- 8565
- NCBI Accession
- NP_003671
- UniProt
- P54577
-